The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for V Patel


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Scaffold hopping towards potent and selective JAK3 inhibitors: discovery of novel C-5 substituted pyrrolopyrazines.EBI
Hoffmann-La Roche
Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors.EBI
Hoffmann-La Roche
Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome.EBI
F. Hoffmann-La Roche
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.EBI
F. Hoffmann-La Roche
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase.EBI
TBA
Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.EBI
Harvard School of Public Health
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.EBI
The Broad Institute of Harvard and Mit
Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates.EBI
Wyeth Research
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.EBI
Pharmacopeia
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.EBI
Novartis Institute For Tropical Diseases
Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.EBI
Novartis Institute For Tropical Diseases
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta.EBI
Artios Pharma
Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ.EBI
Monash University
Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors - Lead optimization - Part III.EBI
Sanofi
Maslinic and oleanolic acids derivatives for treating SARS-CoV-2 infectionBDB
King Abdulaziz University
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agentsBDB
Bayer Pharma Aktiengesellschaft
Compounds, pharmaceutical composition and their use in treating neurodegenerative diseasesBDB
Universite De Lille 2 Droit Et Sante
Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases.BDB
University of Anterwerp
Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.BDB
Cardiff University